Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M23,545Revenue (TTM) $M4,825Net Margin (%)7.8Altman Z-Score3.7
Enterprise Value $M27,360EPS (TTM) $0.8Operating Margin %22.9Piotroski F-Score7
P/E(ttm)62.4Beneish M-Score-2.4Pre-tax Margin (%)13.4Higher ROA y-yN
Price/Book20.310-y EBITDA Growth Rate %--Quick Ratio1.6Cash flow > EarningsY
Price/Sales4.95-y EBITDA Growth Rate %17.6Current Ratio2.8Lower Leverage y-yN
Price/Free Cash Flow55.3y-y EBITDA Growth Rate %-12.5ROA % (ttm)5.4Higher Current Ratio y-yY
Dividend Yield %0.8PEG3.5ROE % (ttm)32.0Less Shares Outstanding y-yY
Payout Ratio %47.0Shares Outstanding M496ROIC % (ttm)18.4Gross Margin Increase y-yY

Gurus Latest Trades with ZTS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZTSGeorge Soros 2016-03-31 Reduce-0.95%$39.33 - $48.02
($42.51)
$ 47.4512%Reduce -31.58%2,316,921
ZTSRobert Olstein 2016-03-31 Buy 0.49%$39.33 - $48.02
($42.51)
$ 47.4512%New holding82,000
ZTSVanguard Health Care Fund 2016-03-31 Sold Out -0.41%$39.33 - $48.02
($42.51)
$ 47.4512%Sold Out0
ZTSFirst Eagle Investment 2016-03-31 Buy 0.32%$39.33 - $48.02
($42.51)
$ 47.4512%New holding2,812,702
ZTSJohn Keeley 2016-03-31 Add0.07%$39.33 - $48.02
($42.51)
$ 47.4512%Add 119.97%78,974
ZTSJoel Greenblatt 2016-03-31 Buy 0.05%$39.33 - $48.02
($42.51)
$ 47.4512%New holding96,665
ZTSRuane Cunniff 2016-03-31 Reduce-0.01%$39.33 - $48.02
($42.51)
$ 47.4512%Reduce -16.34%126,783
ZTSMario Gabelli 2016-03-31 Reduce$39.33 - $48.02
($42.51)
$ 47.4512%Reduce -2.25%579,052
ZTSGeorge Soros 2015-12-31 Reduce-0.09%$40.8 - $48.33
($45.32)
$ 47.455%Reduce -3.82%3,386,512
ZTSVanguard Health Care Fund 2015-12-31 Reduce-0.05%$40.8 - $48.33
($45.32)
$ 47.455%Reduce -11.50%4,251,727
ZTSJohn Keeley 2015-12-31 Reduce-0.03%$40.8 - $48.33
($45.32)
$ 47.455%Reduce -38.60%35,902
ZTSMario Gabelli 2015-12-31 Reduce-0.01%$40.8 - $48.33
($45.32)
$ 47.455%Reduce -3.81%592,363
ZTSRuane Cunniff 2015-12-31 Reduce$40.8 - $48.33
($45.32)
$ 47.455%Reduce -2.92%151,537
ZTSGeorge Soros 2015-09-30 Add0.55%$39.65 - $50.02
($46.41)
$ 47.452%Add 28.29%3,520,997
ZTSRobert Olstein 2015-09-30 Sold Out -0.1%$39.65 - $50.02
($46.41)
$ 47.452%Sold Out0
ZTSFirst Eagle Investment 2015-09-30 Sold Out -0.06%$39.65 - $50.02
($46.37)
$ 47.452%Sold Out0
ZTSVanguard Health Care Fund 2015-09-30 Reduce-0.03%$39.65 - $50.02
($46.41)
$ 47.452%Reduce -6.09%4,804,337
ZTSMario Gabelli 2015-09-30 Reduce-0.02%$39.65 - $50.02
($46.41)
$ 47.452%Reduce -11.41%615,801
ZTSJohn Keeley 2015-09-30 Reduce$39.65 - $50.02
($46.41)
$ 47.452%Reduce -3.94%58,474
ZTSRuane Cunniff 2015-09-30 Add$39.65 - $50.02
($46.41)
$ 47.452%Add 3.27%156,094
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZTS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ZTS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pershing Square Capital ManageDirector 2016-05-09Sell16,850,000$46.551.93view
Pershing Square Capital ManageDirector 2015-07-01Sell1,540,713$48.22-1.6view
MCCALLISTER MICHAEL BDirector 2013-08-08Buy7,000$31.3551.36view
Lagano RoxanneExecutive Vice President 2013-02-06Buy2,000$2682.5view
Lee Joyce J.Executive Vice President 2013-02-06Buy2,000$2682.5view
Lewis Clinton A. Jr.Executive Vice President 2013-02-06Buy500$2682.5view
DAMELIO FRANK ADirector 2013-02-06Buy5,000$2682.5view
Germano Geno JDirector 2013-02-06Buy5,000$2682.5view
Giordano Douglas E.Director 2013-02-06Buy5,000$2682.5view
HILL CHARLES HDirector 2013-02-06Buy5,000$2682.5view

Quarterly/Annual Reports about ZTS:

News about ZTS:

Articles On GuruFocus.com
Bill Ackman Slashes Position in Zoetis May 20 2016 
All-In-One Screener Finds Week's Largest Insider Trades May 13 2016 
Bill Ackman Comments on Zoetis Inc. May 11 2016 
Ackman Selling Zoetis, But Other Firms Are Jumping In May 10 2016 
Robert Olstein Buys Disney, Zoetis, Michael Kors in the 1st Quarter May 09 2016 
First Eagle Buys Zoetis, T-Mobile, Advance Auto Parts in 1st Quarter May 09 2016 
First Eagle Investment Boosts Stake in American Express May 06 2016 
Highlights of Bill Ackman’s 1st Quarter Pershing Square Conference Call Apr 06 2016 
Bill Ackman’s Fund Falls by Double Digits Again in January Feb 02 2016 
Bill Ackman's 3rd Quarter Letter to Pershing Square Shareholders Dec 21 2015 

More From Other Websites
Invest in These Top 5 ROE Stocks to Avert Capital Flight Jul 01 2016
Post-Brexit, a Dog Is an Investor's Best Friend Jun 30 2016
Zoetis to Host Webcast and Conference Call on Second Quarter 2016 Financial Results Jun 30 2016
Zoetis to Host Webcast and Conference Call on Second Quarter 2016 Financial Results Jun 30 2016
London-Based Marshall Wace LLP Wins Big From Brexit Bets despite Founders Backing Opposing Camps Jun 29 2016
Steve Cohen's London Expansion Unfazed by Brexit Vote Jun 28 2016
Zoetis, Inc. breached its 50 day moving average in a Bearish Manner : ZTS-US : June 27, 2016 Jun 27 2016
Unleashed: A Wave Of Pet-Friendly Services & Innovations Jun 24 2016
Research Report Initiated on Select Healthcare Equities Jun 21 2016
Zoetis, Inc. – Value Analysis (NYSE:ZTS) : June 17, 2016 Jun 17 2016
Can Zoetis (ZTS) Keep the Earnings Streak Alive This Quarter? Jun 17 2016
5 Top ROE Stocks for Improving Your Portfolio Returns Jun 16 2016
A Deeper Look at Three of Our Top Performing Ultimate Stock-Pickers Jun 15 2016
Zoetis, Inc. breached its 50 day moving average in a Bearish Manner : ZTS-US : June 14, 2016 Jun 14 2016
Cramer's Stop Trading: Mattress Firm, Zoetis Jun 10 2016
Zoetis downgraded by Citigroup Jun 10 2016
Zoetis Shares Won't Play Dead Jun 05 2016
4 Long Ideas From the London Value Investor Conference Jun 04 2016
Zoetis Presents New Data on Lokivetmab, a Therapeutic Antibody for Dogs with Atopic Dermatitis, at... May 31 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)